Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

No reported Net Change in Cash figures are available to summarize.

Net Change in Cash history

Currency unavailable · from the cash flow

No Net Change in Cash data reported for this period type.

Net Change in Cash vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Net Change in Cash for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$181.83M USD+259.5%—256.2%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$138.36M USD-203.9%—1942.9%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$27.12M USD+568.0%+19.1%12051.1%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$23.87M USD-133.6%——
RNAAtrium Therapeutics, Inc.FY2025$0 USD——0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+63.0%+19.1%1099.6%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.